Personalized risk prediction of lateral lymph node metastasis in male papillary thyroid cancer: a sex-specific model leveraging central lymph node ratio

男性乳头状甲状腺癌侧颈淋巴结转移的个体化风险预测:基于中央淋巴结比率的性别特异性模型

阅读:1

Abstract

AIMS: Notable sex-based disparities exist in papillary thyroid carcinoma (PTC), necessitating male-specific models for predicting lateral lymph node metastasis (LLNM) to guide treatment. METHODS: We developed and validated two nomograms, based on central lymph node ratio (LNR) and preoperative ultrasound (US), respectively, using data from 433 male PTC patients who underwent total thyroidectomy (TT) with central and lateral neck lymph node dissection. Multivariable analysis identified key risk factors. Model performance was evaluated using ROC curves, calibration curves, and decision curve analysis (DCA) across training and validation sets. RESULTS: Male patients had 1.33-fold higher odds of central lymph node metastasis (CLNM) and 1.51-fold higher odds of LLNM than female patients (p < 0.05). Multivariable analysis identified multifocality, tumor size >20 mm, preoperative US nodal status, and an elevated LNR as independent risk factors for LLNM in males (p < 0.05). The LNR-based nomogram demonstrated superior predictive accuracy, with AUCs of 0.828 (training), 0.812 (internal validation), and 0.832 (external validation), outperforming the US-based model. Risk stratification using nomogram scores effectively categorized patients into three distinct groups with significantly different LLNM rates. CONCLUSIONS: The nomogram based on the central LNR provides a precise and clinically valuable tool for the individualized prediction of LLNM in male PTC patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。